Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
VEOZA Filmtabl 45 mg 100 Stk
Drug
Veoza, Filmtabletten
Behandlung moderater bis schwerer vasomotorischer Symptome (VMS) bei postmenopausalen Patientinnen
09.98.0. – menopausal discomfort
HAM – Human medicine
FILM – Film-coated tablet
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
12/4/2023
12/3/2028
Dosage strength
Veoza 45 mg, Filmtabletten
Behandlung moderater bis schwerer vasomotorischer Symptome (VMS) bei postmenopausalen Patientinnen
01
Z – approved
Package
7680692320032
In trade from / since 12/4/2023
A/R – Authorised / referenced
100 tablet(s)
003
Z – approved
Declaration
Component
45 mg fezolinetantum
mannitolum
hydroxypropylcellulosum
hydroxypropylcellulosum substitutum humile
cellulosum microcristallinum
magnesii stearas
hypromellosum
talcum
macrogolum 8000
E 171
E 172 (rubrum)
hydroxypropylcellulosum
hydroxypropylcellulosum substitutum humile
cellulosum microcristallinum
magnesii stearas
hypromellosum
talcum
macrogolum 8000
E 171
E 172 (rubrum)
Authorisation holder
7601001000964
Astellas Pharma AG
Richtiring 28
8304 Wallisellen (ZH)
Richtiring 28
8304 Wallisellen (ZH)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.